Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study

Jia Horng Kao, Min Lung Yu, Chi Yi Chen, Cheng Yuan Peng, Ming Yao Chen, Huoling Tang, Qiaoqiao Chen, Jinzi J. Wu

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences